Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers
Frontiers in Cellular and Infection Microbiology · 02.09.2025 · 15
DOI: 10.3389/fcimb.2025.1633227 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 02.09.2025. Verfasst von He Xin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Digestive System Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Helicobacter pylori ( H. pylori ) is a Group 1 gastric carcinogen increasingly implicated in extragastric digestive malignancies. This review synthesizes evidence on its role in liver, biliary, esophageal, colorectal, and pancreatic cancers. Based on its unique spiral morphology, flagellar motility bundle, and urease activity-mediated acidic niche adaptation, H. pylori disrupts host cellular homeostasis through multifactorial virulence mechanisms involving CagA/VacA synergy, and exploits antigenic variation and immunomodulatory strategies to achieve persistent gastric mucosal colonization and chronic infection. Emerging evidence suggests associations between H. pylori infection and nongastric digestive cancers, though relationships vary by site. For hepatocellular carcinoma (HCC), epidemiological studies indicate increased risk (OR 4.75), particularly with HCV coinfection, but mechanistic and cohort data remain conflicting. Biliary tract cancer (BTC) shows stronger epidemiological links, especially for cholangiocarcinoma (OR 4.18), supported by virulence factor detection. In esophageal cancer, H. pylori particularly CagA+ strains demonstrates a protective effect against adenocarcinoma but no significant association with squamous cell carcinoma. Colorectal cancer exhibits complex associations, with meta-analyses suggesting increased risk in East Asian populations and potential benefits from eradication therapy. Pancreatic cancer links remain inconsistent. Proposed mechanisms of H. pylori in extragastric cancers include chronic inflammation, virulence factor activity and microbiome disruption. This comprehensive review synthesizes contemporary evidence on the bacterium’s role in non-gastric digestive malignancies, examines pathways underlying its oncogenicity, and outlines translational implications for risk stratification and therapeutic innovation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Intervention Ward One, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- The State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China.
- Department of Medicine, Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing, China.
- Tianjin Second People's Hospital, Tianjin, China.
- Tianjin Institute of Hepatology, Tianjin, China.
Zitieren
APA
Xin, H., Zhu, C., Zhu, C., Zhang, X., Chen, D., & Wang, Q. (2025). Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1633227
Vancouver
Xin H, Zhu C, Zhu C, Zhang X, Chen D, Wang Q. Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1633227
BibTeX
@article{Xin2025,
author = {Xin, He and Zhu, Chi and Zhu, Chan and Zhang, Xing and Chen, Dongsheng and Wang, Qingping},
title = {Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1633227}
}
EUVIMED